IL-36 receptor agonist and antagonist imbalance drives neutrophilic inflammation in COPD-Reference-Cited by-同舟云学术

IL-36 receptor agonist and antagonist imbalance drives neutrophilic inflammation in COPD

Published:2022-08-08 Issue:15 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Baker Jonathan R.,Fenwick Peter S.,Koss Carolin K.,Owles Harriet B.,Elkin Sarah L.,Fine Jay,Thomas Matthew^ORCID,El Kasmi Karim C.,Barnes Peter J.^ORCID,Donnelly Louise E.

Funder

Boehringer Ingelheim

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/155581/files/pdf

Reference67 articles.

1. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease

3. Inflammatory endotypes in COPD;Barnes;Allergy,2019

4. Biology of IL-36 cytokines and their role in disease

5. Biology of IL-36 Signaling and Its Role in Systemic Inflammatory Diseases

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the STAT3/IL-36G signaling pathway can be a promising approach to treat rosacea;Journal of Advanced Research;2024-06

2. Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation;Cardiovascular Research;2024-04

3. Interleukin-36 receptor antagonist stimulation in vitro inhibits peripheral and lung-resident T cell response isolated from patients with ventilator-associated pneumonia;International Immunopharmacology;2024-03

4. Inflammation as the nexus: exploring the link between acute myocardial infarction and chronic obstructive pulmonary disease;Frontiers in Cardiovascular Medicine;2024-02-21

5. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases;Journal of Investigative Dermatology;2024-02